# Amplitude-modulated Radiofrequency Electromagnetic Field Treatment for Advanced Hepatocellular Carcinoma (Immune-RF)

> **NCT06821958** · NA · RECRUITING · sponsor: **Charite University, Berlin, Germany** · enrollment: 36 (estimated)

## Conditions studied

- Hepatocellular Carcinoma (HCC)

## Interventions

- **DEVICE:** Radiofrequency electromagnetic field treatment

## Key facts

- **NCT ID:** NCT06821958
- **Lead sponsor:** Charite University, Berlin, Germany
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-01
- **Primary completion:** 2026-06-15
- **Final completion:** 2029-02-28
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2025-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06821958

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06821958, "Amplitude-modulated Radiofrequency Electromagnetic Field Treatment for Advanced Hepatocellular Carcinoma (Immune-RF)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06821958. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*